ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report to Shareholders 2023
|
|
Frogster
|
19 |
11K |
11 |
15/10/23 |
15/10/23 |
ASX - By Stock
|
19
|
11K
|
11
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Frogster
|
18 |
7.4K |
6 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
18
|
7.4K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Newsletter II - April 2023
|
|
Frogster
|
11 |
10K |
7 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
11
|
10K
|
7
|
|
ASX - By Stock
|
CUV |
Re:
You have to wonder...
|
|
Frogster
|
2 |
1.2K |
1 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
2
|
1.2K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Progresses CUV104 Vitiligo Study
|
|
Frogster
|
26 |
10K |
0 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
26
|
10K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Progresses CUV104 Vitiligo Study
|
|
Frogster
|
26 |
10K |
1 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
26
|
10K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Progresses CUV104 Vitiligo Study
|
|
Frogster
|
26 |
10K |
5 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
26
|
10K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CUV Appendix 4D Half Year Report
|
|
Frogster
|
42 |
17K |
4 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
42
|
17K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
OTC Novel product range
|
|
Frogster
|
7 |
4.9K |
6 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
7
|
4.9K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report 2022
|
|
Frogster
|
26 |
9.5K |
4 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
26
|
9.5K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report 2022
|
|
Frogster
|
26 |
9.5K |
12 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
26
|
9.5K
|
12
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Appendix 4E and Annual Report 2022
|
|
Frogster
|
26 |
9.5K |
12 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
26
|
9.5K
|
12
|
|
ASX - By Stock
|
CUV |
Re:
Revenue EXPLOSION Coming?
|
|
Frogster
|
137 |
76K |
5 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
137
|
76K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
CUV Charting
|
|
Frogster
|
131 |
67K |
6 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
131
|
67K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Newsletter III - June 2022
|
|
Frogster
|
8 |
4.0K |
3 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
8
|
4.0K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Becoming a substantial holder
|
|
Frogster
|
9 |
5.1K |
11 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
9
|
5.1K
|
11
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Positive Final Results in Stroke Study CUV801
|
|
Frogster
|
35 |
14K |
5 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
35
|
14K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Notification regarding unquoted securities - CUV
|
|
Frogster
|
4 |
1.6K |
1 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Positive Final Results in Stroke Study CUV801
|
|
Frogster
|
35 |
14K |
3 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
35
|
14K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Frogster
|
26 |
11K |
1 |
01/05/22 |
01/05/22 |
ASX - By Stock
|
26
|
11K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Frogster
|
26 |
11K |
14 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
26
|
11K
|
14
|
|
ASX - By Stock
|
CUV |
Re:
Margin lending LVR
|
|
Frogster
|
35 |
15K |
5 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
35
|
15K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Frogster
|
748 |
293K |
8 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
748
|
293K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Frogster
|
748 |
293K |
8 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
748
|
293K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
CLINUVEL AVOIDS 2ND STRIKE, AUSSIE BIOTECH GOES FROM STRENGTH TO STRENGTH (possible AFR headline tomorrrow)
|
|
Frogster
|
9 |
4.4K |
14 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
9
|
4.4K
|
14
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Afamelanotide well tolerated by first stroke patients
|
|
Frogster
|
10 |
5.8K |
9 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
10
|
5.8K
|
9
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Frogster
|
42 |
13K |
6 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
42
|
13K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Frogster
|
42 |
13K |
7 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
42
|
13K
|
7
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Frogster
|
30 |
9.2K |
2 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
30
|
9.2K
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change of Director's Interest Notice
|
|
Frogster
|
30 |
9.2K |
2 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
30
|
9.2K
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Revenue EXPLOSION Coming?
|
|
Frogster
|
137 |
76K |
8 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
137
|
76K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Media release - First stroke patient with afamelanotide
|
|
Frogster
|
34 |
10K |
12 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
34
|
10K
|
12
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Media release - First stroke patient with afamelanotide
|
|
Frogster
|
34 |
10K |
7 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
34
|
10K
|
7
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Media release - First stroke patient with afamelanotide
|
|
Frogster
|
34 |
10K |
4 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
34
|
10K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Media release - First stroke patient with afamelanotide
|
|
Frogster
|
34 |
10K |
6 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
34
|
10K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Clinuvel compared to Imugene
|
|
Frogster
|
64 |
40K |
13 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
64
|
40K
|
13
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Media Release - TGA approves SCENESSE
|
|
Frogster
|
18 |
5.2K |
6 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
18
|
5.2K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Frogster
|
748 |
293K |
5 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
748
|
293K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Further Research Coverage Initiated on CLINUVEL
|
|
Frogster
|
5 |
2.7K |
8 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
5
|
2.7K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Frogster
|
748 |
293K |
1 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
748
|
293K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Frogster
|
748 |
293K |
6 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
748
|
293K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
DNA REPAIR
|
|
Frogster
|
13 |
6.6K |
6 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
13
|
6.6K
|
6
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Presentation - Value in the Vines Investor Conference
|
|
Frogster
|
3 |
1.4K |
9 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
3
|
1.4K
|
9
|
|
ASX - By Stock
|
CUV |
Re:
CUV - banter and discussion
|
|
Frogster
|
52 |
22K |
8 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
52
|
22K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Newsletter
|
|
Frogster
|
3 |
1.9K |
18 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
3
|
1.9K
|
18
|
|
ASX - By Stock
|
CUV |
Re:
Ann: First patient dosed in SCENESSE DNA Repair Program
|
|
Frogster
|
14 |
5.3K |
14 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
14
|
5.3K
|
14
|
|
ASX - By Stock
|
CUV |
Re:
CUV - banter and discussion
|
|
Frogster
|
52 |
22K |
11 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
52
|
22K
|
11
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE in DNA Repair
|
|
Frogster
|
9 |
2.9K |
7 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
9
|
2.9K
|
7
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Proposed issue of Securities - CUV
|
|
Frogster
|
3 |
1.6K |
4 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Frogster
|
748 |
293K |
4 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
748
|
293K
|
4
|
|